HROW HARROW, INC. Insider Trading

Director Graves purchases 1,000 shares of HROW at $31.07; stock down 43.7% from 52-week high amid cluster buying by 2 other insiders in past 14 days.

Director Adrienne L. Graves purchased 1,000 shares at $31.07 on 2026-05-18, establishing an initial position in HARROW, INC. This buy occurs within a cluster pattern: 2 other insiders also purchased shares within the past 14 days. The transaction takes place as the stock trades $30.90, down 43.7% from its 52-week high of $54.85 and 25.5% lower over the past 30 days. HARROW reported $44.2M in quarterly revenue with +36.4% annual growth, yet remains unprofitable with $-27.6M net income in its most recent full fiscal year. The convergence of a new director position acquisition with synchronized insider buying during significant price weakness and an unprofitable operating environment merits examination of what prompted the buy timing and whether valuation or strategic factors are driving the cluster activity.

Director Lauren P Silvernail buys 1,000 shares at $31.00 amid cluster buy; stock down -43.7% from 52-week high.

Lauren P Silvernail, a Director, purchased 1,000 shares at $31.00 on 2026-05-18 at a total value of $31,000.00, establishing an initial 1.0K share position. This transaction is part of a cluster buy pattern, with 3 other insiders also purchasing within the past 14 days. The timing occurs after significant price deterioration: the stock is currently trading at $30.90, down -43.7% from its 52-week high of $54.85 and down -25.5% over the past 30 days. The company reported revenue of $44.2M in its latest quarter but posted a net loss of $-27.6M and is unprofitable on a full-year basis, despite annual revenue growth of +36.4%. Multiple insider purchases concurrent with steep price declines and operational losses warrant investor attention to understand the board's perspective on current valuation and operational trajectory.

HROW CEO Mark L Baum buys 10,000 shares at $30.20; stock down 43.7% from 52-week high amid unprofitability.

CEO Mark L Baum purchased 10,000 shares at $30.20, increasing his holdings to 3.00M shares, at a time when HROW has declined 43.7% from its 52-week high of $54.85 and 35.3% over 90 days. The company remains unprofitable with net income of $-27.6M against quarterly revenue of $44.2M, though annual revenue growth reached 36.4%. Baum's cross-ticker track record shows 3 prior open-market buys with a 90-day win rate of 100.00%, though his same-ticker history at HROW includes only 1 measurable outcome (the 2024-03-22 buy yielded +72.0% over 90 days), with two other HROW purchases lacking measurable outcomes yet. The buy occurs as the stock trades 43.7% below its recent peak, presenting a material disconnect between the CEO's trading activity and the company's current operating loss position.

CFO Andrew R. Boll buys 3,500 shares of HROW at $29.90 amid -35.3% 90-day decline and unprofitable operations

Andrew R. Boll, President and CFO of HARROW, INC., purchased 3,500 shares at $29.90, increasing his holdings from 811.2K to 814.7K shares. The transaction occurred against a backdrop of significant recent stock deterioration: the stock is down 35.3% over 90 days and 43.7% from its 52-week high of $54.85, though the company is growing revenue at 36.4% year-over-year. The company reported negative net income despite $44.2M in latest-quarter revenue, indicating profitability challenges persist despite strong top-line growth. This small open-market purchase by a senior executive in a materially depressed valuation window may warrant monitoring for patterns in follow-on transactions.